Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jul 3;71(8):1132–1140. doi: 10.1002/acr.23724

Table 3.

Predictors of Any Documented Prescription Contraception versus No Documented Contraception (n=2455)

Unadjusted
OR (95%CI)  p value
Adjusted
OR (95%CI)  p value
FDA Medication Risk Category
Class D/X 1.04 (0.86-1.26) 0.68 1.04 (0.84-1.29) 0.69
Class A/B/C REF REF
Outpatient Clinic Visits
Rheumatology Visits ˃ 2
Visits = 2
1.22 (1.01-1.47)
REF
0.036 1.22 (1.0-1.50)
REF
0.06
PCP Visit ≥1
Visits <1
1.75 (1.48-2.08)
REF
<0.0001 1.43 (1.18-1.73)
REF
<0.0001
Gynecology Visit ≥1
Visits <1
3.53 (2.95-4.23)
REF
<0.0001 3.35 (2.77-4.05)
REF
<0.0001

Table 3 includes unadjusted and adjusted odds ratios. Reference category for all models is No Documented Contraception. Adjusted models include all covariates in addition to age, race, and marital status.